PSYCHEMEDICS CORP's ticker is PMD and the CUSIP is 744375205. A total of 38 filers reported holding PSYCHEMEDICS CORP in Q3 2015. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2019 | $239,000 | -0.8% | 17,000 | +11.8% | 0.02% | -13.0% |
Q4 2018 | $241,000 | +28.2% | 15,200 | +52.0% | 0.02% | +53.3% |
Q3 2018 | $188,000 | -85.6% | 10,000 | -89.5% | 0.02% | -90.1% |
Q2 2016 | $1,310,000 | -35.6% | 95,360 | -35.5% | 0.15% | -38.9% |
Q1 2016 | $2,034,000 | -99.9% | 147,908 | -23.6% | 0.25% | +4.2% |
Q4 2015 | $1,962,090,000 | +100778.7% | 193,500 | 0.0% | 0.24% | -10.9% |
Q3 2015 | $1,945,000 | -32.2% | 193,500 | 0.0% | 0.27% | -26.3% |
Q2 2015 | $2,870,000 | -10.6% | 193,500 | 0.0% | 0.36% | -9.8% |
Q1 2015 | $3,210,000 | +9.5% | 193,500 | 0.0% | 0.40% | +6.1% |
Q4 2014 | $2,932,000 | +7.0% | 193,500 | 0.0% | 0.38% | -1.6% |
Q3 2014 | $2,740,000 | 0.0% | 193,500 | 0.0% | 0.38% | +4.4% |
Q2 2014 | $2,740,000 | -2.5% | 193,500 | +17.9% | 0.37% | -4.7% |
Q1 2014 | $2,811,000 | +2.0% | 164,106 | -12.6% | 0.38% | +3.8% |
Q4 2013 | $2,757,000 | +5.6% | 187,694 | -4.8% | 0.37% | -8.8% |
Q3 2013 | $2,612,000 | +15.8% | 197,100 | -6.2% | 0.41% | +2.5% |
Q2 2013 | $2,256,000 | – | 210,090 | – | 0.40% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Tieton Capital Management, LLC | 250,388 | $3,974,000 | 4.46% |
QUANTUM CAPITAL MANAGEMENT | 63,246 | $1,004,000 | 0.58% |
Mill Road Capital Management LLC | 14,896 | $236,000 | 0.30% |
Gs Investments, Inc. | 15,800 | $250,746,000 | 0.21% |
RBF Capital, LLC | 87,917 | $1,395,000 | 0.18% |
North Star Investment Management Corp. | 85,282 | $1,353,000 | 0.18% |
CRAWFORD INVESTMENT COUNSEL INC | 297,675 | $4,724,000 | 0.16% |
Uniplan Investment Counsel, Inc. | 145,677 | $2,311,000 | 0.16% |
DEPRINCE RACE & ZOLLO INC | 282,186 | $4,478,000 | 0.13% |
Moors & Cabot, Inc. | 37,932 | $605,000 | 0.10% |